Assisting Social Security Disability Insurance Beneficiaries With Schizophrenia, Bipolar Disorder, or Major Depression in Returning to Work

被引:81
|
作者
Drake, Robert E. [1 ]
Frey, William
Bond, Gary R.
Goldman, Howard H.
Salkever, David
Miller, Alexander
Moore, Troy A.
Riley, Jarnee
Karakus, Mustafa
Milfort, Roline
机构
[1] Dartmouth Psychiat Res Ctr, Geisel Sch Med Dartmouth, Hanover, NH USA
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2013年 / 170卷 / 12期
关键词
INDIVIDUAL PLACEMENT; SUPPORTED EMPLOYMENT; CARE; PERFORMANCE; FIDELITY; ILLNESS; PEOPLE; SCALE; COSTS; MODEL;
D O I
10.1176/appi.ajp.2013.13020214
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: People with psychiatric impairments (primarily schizophrenia or a mood disorder) are the largest and fastest-growing group of Social Security Disability Insurance (SSDI) beneficiaries. The authors investigated whether evidence-based supported employment and mental health treatments can improve vocational and mental health recovery for this population. Method: Using a randomized controlled trial design, the authors tested a multifaceted intervention: team-based supported employment, systematic medication management, and other behavioral health services, along with elimination of barriers by providing complete health insurance coverage (with no out-of-pocket expenses) and suspending disability reviews. The control group received usual services. Paid employment was the primary outcome measure, and overall mental health and quality of life were secondary outcome measures. Results: Overall, 2,059 SSDI beneficiaries with schizophrenia, bipolar disorder, or depression in 23 cities participated in the 2-year intervention. The teams implemented the intervention package with acceptable fidelity. The intervention group experienced more paid employment (60.3% compared with 40.2%) and reported better mental health and quality of life than the control group. Conclusions: Implementation of the complex intervention in routine mental health treatment settings was feasible, and the intervention was effective in assisting individuals disabled by schizophrenia or depression to return to work and improve their mental health and quality of life.
引用
收藏
页码:1433 / 1441
页数:9
相关论文
共 50 条
  • [21] Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression
    S H Fatemi
    J A Earle
    T McMenomy
    Molecular Psychiatry, 2000, 5 : 654 - 663
  • [22] Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression
    Fatemi, SH
    Earle, JA
    McMenomy, T
    MOLECULAR PSYCHIATRY, 2000, 5 (06) : 654 - 663
  • [23] Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depression
    Beasley, CL
    Cotter, DR
    Everall, IP
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 105 - 105
  • [24] Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder
    Zhao, Qing
    Ma, Yan-tao
    Lui, Simon S. Y.
    Liu, Wen-hua
    Xu, Ting
    Yu, Xin
    Tan, Shu-Ping
    Wang, Zhi-ren
    Qu, Miao
    Wang, Ya
    Huang, Jia
    Cheung, Eric F. C.
    Dazzan, Paola
    Chan, Raymond C. K.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 43 : 72 - 78
  • [25] Association of cancer and schizophrenia, major depression and bipolar disorder: A Mendelian randomization study
    Han, Xinyue
    Lin, Xiangying
    Li, Guanhong
    Wang, Jingnan
    Meng, Xiangxue
    Chen, Tongyu
    Zhang, Yanbo
    Fu, Xiaoling
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2024, 183
  • [26] Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population
    Musliner, Katherine L.
    Mortensen, Preben B.
    McGrath, John J.
    Suppli, Nis P.
    Hougaard, David M.
    Bybjerg-Grauholm, Jonas
    Baekvad-Hansen, Marie
    Andreassen, Ole
    Pedersen, Carsten B.
    Pedersen, Marianne G.
    Mors, Ole
    Nordentoft, Merete
    Borglum, Anders D.
    Werge, Thomas
    Agerbo, Esben
    Stahl, Eli A.
    Breen, Gerome
    Forstner, Andreas J.
    McQuillin, Andrew
    Ripke, Stephan
    Trubetskoy, Vassily
    Mattheisen, Manuel
    Wang, Yunpeng
    Coleman, Jonathan R., I
    Gaspar, Helena A.
    de Leeuw, Christiaan A.
    Steinberg, Stacy
    Pavlides, Jennifer M. Whitehead
    Trzaskowski, Maciej
    Pers, Tune H.
    Holmans, Peter A.
    Abbott, Liam
    Agerbo, Esben
    Akil, Huda
    Albani, Diego
    Alliey-Rodriguez, Ney
    Als, Thomas D.
    Anjorin, Adebayo
    Antilla, Verneri
    Awasthi, Swapnil
    Badner, Judith A.
    Etzekvad-Hansen, Marie
    Barchas, Jack D.
    Bass, Nicholas
    Bauer, Michael
    Belliveau, Richard
    Bergen, Sarah E.
    Pedersen, Carsten Bocker
    Boen, Erlend
    Boks, Marco
    JAMA PSYCHIATRY, 2019, 76 (05) : 516 - 525
  • [27] Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder
    Toomey, R
    Faraone, SV
    Simpson, JC
    Tsuang, MT
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 24 - 24
  • [28] Homer1a protein expression in schizophrenia, bipolar disorder, and major depression
    Stefan L. Leber
    Ida C. Llenos
    Christine L. Miller
    Jeannette R. Dulay
    Johannes Haybaeck
    Serge Weis
    Journal of Neural Transmission, 2017, 124 : 1261 - 1273
  • [29] Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder
    Toomey, R
    Faraone, SV
    Simpson, JC
    Tsuang, MT
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1998, 186 (08) : 470 - 476
  • [30] Intellectual disability and other neuropsychiatric outcomes in high-risk children of mothers with schizophrenia, bipolar disorder and unipolar major depression
    Morgan, Vera A.
    Croft, Maxine L.
    Valuri, Giulietta M.
    Zubrick, Stephen R.
    Bower, Carol
    McNeil, Thomas F.
    Jablensky, Assen V.
    BRITISH JOURNAL OF PSYCHIATRY, 2012, 200 (04) : 282 - 289